Home

Welcome to RECONNECT Fragile X Study Website.

Currently there are no approved therapies for the treatment of Fragile X syndrome, a rare genetic disorder.

This research study is currently enrolling children and adolescents ages 3 to 17 years of age with Fragile X syndrome.

To see if someone you love may be able to participate, please apply to learn more.

Children Are Our Commitment

Learn more about a clinical trial evaluating investigational cannabidiol (CBD) gel to see if it helps behavioral issues related to Fragile X syndrome.

Qualified participants are:

  • Between 3 and 17 years of age
  • Diagnosed via genetic testing, with Fragile X syndrome
  • In generally good health